Background: As a progressive neurodegenerative disease, the comprehensive understanding of the pathogenesis of Alzheimer’s disease (AD) is yet to be clarified. Modifications in RNA, including m6A/m5C/m1A, affect the onset and progression of many diseases. Consequently, this study focuses on the role of methylation modification in the pathogenesis of AD. Materials and methods: Three AD-related datasets, namely GSE33000, GSE122063, and GSE44770, were acquired from GEO.